Induction of the progesterone receptor gene in estrogen target cells monitored by branched DNA signal amplification☆ ☆This work originated at the R.W. Johnson Pharmaceutical Research Institute, Raritan, New Jersey, USA.-Reference-Cited by-同舟云学术

Induction of the progesterone receptor gene in estrogen target cells monitored by branched DNA signal amplification☆ ☆This work originated at the R.W. Johnson Pharmaceutical Research Institute, Raritan, New Jersey, USA.

Published:2001-09 Issue:9 Volume:66 Page:663-671
ISSN:0039-128X
Container-title:Steroids
language:en
Short-container-title:Steroids

Author:

Allan George F,Hutchins Amy,Liu Xiulin,Clancy Joanna

Publisher

Elsevier BV

Subject

Organic Chemistry,Clinical Biochemistry,Pharmacology,Endocrinology,Molecular Biology,Biochemistry

Reference44 articles.

1. The biology of menopause;Yen;J Reprod Med,1977

2. Estrogen and progesterone receptors;Allan,2000

3. Effects of steroid hormones and antisteroids on alkaline phosphatase activity in human endometrial cancer cells (Ishikawa line);Holinka;Cancer Res,1986

4. Progestin regulation of alkaline phosphatase in the human breast cancer cell line T47D;Di Lorenzo;Cancer Res,1991

5. Synthetic estrogen 17α-ethinyl estradiol induces pattern of uterine gene expression similar to endogenous estrogen 17β -estradiol;Hyder;J Pharmacol Exp Ther,1999

Cited by 8 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Cytochrome P450-mediated estrogen catabolism therapeutic avenues in epilepsy;Acta Neurologica Belgica;2020-08-02

2. The Neuropeptide Y Y1 Receptor: A Diagnostic Marker? Expression in MCF-7 Breast Cancer Cells Is Down-Regulated by Antiestrogens In Vitro and in Xenografts;PLoS ONE;2012-12-07

3. Tissue Selective Estrogen Complexes (TSECs) Differentially Modulate Markers of Proliferation and Differentiation in Endometrial Cells;Reproductive Sciences;2012-11-20

4. Incidence and prognostic factors of Japanese breast cancer patients with bone metastasis;Journal of Orthopaedic Science;2006-01

5. Endoxifen (4-hydroxy-N-desmethyl-tamoxifen) has anti-estrogenic effects in breast cancer cells with potency similar to 4-hydroxy-tamoxifen;Cancer Chemotherapy and Pharmacology;2005-02-01